Novel cell-penetrating peptides derived from the Ku DNA-binding protein efficiently enter cells and deliver plasmid DNA, with the lead peptide Ku-P4 showing high internalization and biocompatibility.
High internalization + biocompatibilityKu-P4 combines efficient cell penetration with safety — achieving high intracellular delivery of DNA polyplexes without the toxicity that limits many potent cell-penetrating peptides.
What the researchers found
Ku-P4, derived from the intrinsically disordered tail extensions of Ku proteins, showed high cell internalization efficacy and biocompatibility. Biophysical studies identified the proline residue as crucial for maintaining the disordered state that enables both biocompatibility and cell penetration. Ku-P4 effectively condensed DNA into positively charged polyplexes that penetrated cell membranes and delivered plasmid DNA intracellularly. The peptides represent a new class of CPPs based on intrinsically disordered protein regions.
Why it matters
Cell-penetrating peptides are essential tools for delivering drugs and gene therapies that can't cross cell membranes on their own. Most current CPPs are based on viral or toxin-derived sequences, which can have toxicity issues. Deriving CPPs from a human DNA-repair protein (Ku) represents a novel, potentially safer approach. The finding that structural disorder is key to function provides important design principles for next-generation delivery peptides.
How the study worked
Researchers designed peptides derived from the flexible, disordered tail extensions of Ku DNA-binding proteins. Multiple peptide variants were synthesized and tested for cell penetration efficiency, biocompatibility, and structural properties. Biophysical studies characterized the peptides' structural disorder and the role of proline residues. DNA binding and condensation were assessed to form polyplexes. Cell membrane penetration and intracellular DNA delivery were evaluated in cell culture.
What this study cannot tell us
All experiments were conducted in cell culture — no in vivo delivery data were generated. The efficiency of DNA delivery relative to established transfection methods was not quantitatively compared. The mechanism of cell penetration (endocytosis vs. direct translocation) was not fully characterized. Stability in biological fluids and potential for immune responses were not assessed. The study used plasmid DNA but did not test delivery of other cargo types (proteins, small molecules, siRNA).
How to read the evidence
This is an in vitro proof-of-concept study introducing a new class of cell-penetrating peptides. The biophysical characterization and cell delivery demonstrations are methodologically sound, but no in vivo data or comparison to existing CPPs were provided.
When this study was published
Published in 2023, this study represents a recent contribution to the growing field of rationally designed cell-penetrating peptides for therapeutic delivery.
The bigger picture
Cell-penetrating peptides are fundamental to the future of drug delivery and gene therapy. As CRISPR, mRNA therapies, and peptide drugs advance, efficient intracellular delivery becomes the rate-limiting step. This study expands the CPP toolkit by introducing a new class based on intrinsically disordered protein regions — a design principle that could be applied to many other protein sources to create diverse delivery vehicles.
Questions still open
- How does Ku-P4's delivery efficiency compare to established CPPs like TAT or penetratin in head-to-head comparisons?
- Can Ku-P4 deliver other therapeutic cargo beyond plasmid DNA, such as siRNA, mRNA, or peptide drugs?
- Does the intrinsically disordered design principle translate to improved in vivo delivery and reduced immunogenicity?
Common questions
What are cell-penetrating peptides and why do they matter?
Why is a disordered peptide structure beneficial for cell penetration?
Read the original research
Intrinsically Disordered Ku Protein-Derived Cell-Penetrating Peptides.
ACS bio & med chem Au, 3(6), 471-479
Citation
Maity, Biswanath; Moorthy, Hariharan; Govindaraju, Thimmaiah. (2023). Intrinsically Disordered Ku Protein-Derived Cell-Penetrating Peptides.. ACS bio & med chem Au, 3(6), 471-479. https://doi.org/10.1021/acsbiomedchemau.3c00032